| SEPTEMBER 11, 2026 |
| Deal value | $70M invested |
| Ownership | VC-backed · NewView Capital, Insight Partners, Primary Venture Partners, Scale Venture Partners, Vintage Investment Partners +4 more |
| Capital raised | $225M |
| Headcount | 178 FTEs |
| Headquarters | Brooklyn, New York |
| Leadership | Michael Wang, Founder and Chief Clinical Officer Alex Hejnosz, Chief Executive Officer |
| Headquarters | Burlingame, California |
| Deal team | Nick Bunick, Partner |